📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions. (2020)

First Author: George CN

Attributed to: the roleDefining of IL-1B in breast cancer bone metastasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2020.100317

PubMed Identifier: 32995253

Publication URI: http://europepmc.org/abstract/MED/32995253

Type: Journal Article/Review

Volume: 25

Parent Publication: Journal of bone oncology

ISSN: 2212-1366